WFDC2 and ovarian cancer: HE4-overexpressing OVCAR3 ovarian cancer cells were found to have a marked increase in activation of protein kinase B (AKT) compared with control cells, while HE4 knockdown in OVCAR3 cells reduced AKT activation (12).